Mani Foroohar

Mani Foroohar

Analyst-Equity presso Leerink Partners LLC

Finance
Consumer Services

Profilo

Dr. Mani Foroohar is a Senior Managing Director of Genetic Medicines at Leerink Partners LLC.
He is also a Senior Research Analyst within the Therapeutics team focusing on Genetic Medicines.
Dr. Foroohar joins Leerink from Aptigon Capital, a Citadel Company, where he most recently was a Therapeutics Analyst focused on U.S.
and EU biotechnology, major pharmaceuticals and specialty pharmaceuticals sectors.
Prior to Aptigon, he was an Analyst at Green Owl Capital Management and an Assistant Vice President of Equity Research at Barclays.
In 2013, he co-founded Cellanyx Diagnostics, a company developing a proprietary live tumor cell, phenotypic platform for precision risk stratification in cancer to inform clinical treatment decision making.
Dr. Foroohar holds an M.D.
from Stanford, where he was a Howard Hughes Medical Institute Research Fellow in the Department of Genetics, M.B.A.
from Columbia, and a B.S.
from UCLA.

Posizioni attive di Mani Foroohar

SocietàPosizioneInizio
Analyst-Equity 01/05/2018
Tutte le posizioni attive di Mani Foroohar

Precedenti posizioni note di Mani Foroohar

SocietàPosizioneFine
Analyst-Equity 01/12/2014
Analyst-Equity -
Vedi nel dettaglio l'esperienza di Mani Foroohar

Formazione di Mani Foroohar

University of California, Los Angeles Undergraduate Degree
Stanford University School of Medicine Doctorate Degree
Columbia Business School Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Mani Foroohar

Relazioni

100 +

Relazioni di 1° grado

6

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private3

Finance

Finance

Finance

Vedi le connessioni aziendali
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA